EP1410 - ECE_1202 - Individualized endocrine care in non-binary individuals: efficacy, safety, and long-term outcomes of microdosing and selective hormone modulators
European Journal of Endocrinology August 10, 2026 Ipsita Mishra
Abstract Background Current gender-affirming hormone therapy (GAHT) guidelines are optimized for binary outcomes (full masculinization or feminization), leaving a critical evidence gap for the growing population of non-binary and gender-diverse (NBGD) individuals who seek partial physical changes. These non-traditional therapeutic goals often necessitate the off-label use of low-dose,...